Zoetis is inviting equine veterinary surgeons to a training day in Newbury on 24th June 2026 designed to strengthen consultation skills, improve client compliance and build professional confidence.

The event, titled "Confident Communication in Equine…

Zoetis, formerly Pfizer Animal Health has launched Ovatec Plus, which it claims will make equine faecal collection and in-practice worm count testing quicker and easier.

Ovatec Plus is designed to facilitate the in-house detection of worm burdens…

Zoetis, maker of Zylexis, is highlighting a new review published in Veterinary Immunology and Immunopathology, which has concluded that immune-modulators may provide a valuable contribution to the reduction of some equine respiratory diseases

The study…

Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.

Flexi4 contains…

Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.

Equine Gastric Ulceration…

Zoetis has announced the launch of Contacera (meloxicam) 15mg/ml oral suspension, a non-steriodal anti-inflammatory preparation for horses.

According to the company, meloxicam has been shown to hold advantages over Phenylbutazone for the alleviation of…

Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.

The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices…

Zoetis has announced that Horse & Country TV (Sky Channel 253) will be airing the Vet Essentials episode on worm control in horses from today until 26th March.

The programme, made in association with Zoetis, follows presenter Jenny Rudall on her…

Zoetis, the maker of UlcerGold, has announced the launch of a digital tool to support veterinary surgeons with the diagnosis of Equine Gastric Ulceration Syndrome (EGUS).

The new tool is part of a package that also includes posters and SMS texts to…

Zoetis has produced new guidance to help veterinary surgeons develop successful strategies for controlling worms in foals and youngstock.

According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal…

Zoetis has announced that its Equip EHV 1,4 vaccine is now available and that it has made arrangements to supply an alternative rotavirus vaccine when Equip Rotavirus goes out of stock later this month.

Equip EHV 1,4 is licensed for the active immunisation…

Zoetis has announced that its equine viral arteritis (EVA) vaccine, Equip Artervac, is back in stock.

The company warned last year that Equip Artervac would be out of stock from the end of November 2017 until mid-2018, but says that the re-availability…

Zoetis has announced that it will continue to supply an alternative equine rotavirus vaccine under a Wholesale Dealer Import Certificate (WDIC) until normal supply of its licensed product, Equip Rotavirus, can be restored.

Zoetis reports that its stock of Equip Artervac, its Equine Viral Arteritis (EVA) vaccine, is due to expire on 13th December, and new stocks are not expected before February 2019.

Equip Artervac is indicated for the active immunisation for horses against…

Zoetis has announced that announced its Equine Viral Arteritis (EVA) vaccine Equip Artervac is now back in stock.

Supplies of the vaccine, which is indicated for the active immunisation for horses against equine arteritis, ran low at the end of last year…

Aware that many horse owners will be worried about the outbreak of equine flu and want to know more about available vaccines, Zoetis has issued a statement for veterinary professionals about its vaccines, Equip Flu and Equip Flu and Tetanus (Equip F or Equip…

In the light of concerns caused by the recent flu outbreak, Zoetis is urging equine vets to participate in a new survey about Equine Herpes Virus (EHV), for which you could win a new body warmer.

The company says the aim is to identify the most effective…

Zoetis has launched Stablelab, a hand-held, point-of-care blood test that gives veterinary surgeons diagnostic information about equine inflammation in 10 minutes.

The Stablelab hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA…

Zoetis is hosting a free equine dental CPD webinar presented by Specialists Chris Pearce and Nicole du Toit, to help equine vets build their knowledge on selection criteria for modern dentistry techniques.

The hour-long webinar will be held on Tuesday 18th…

Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis

The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end…

Zoetis has added AI equine faecal egg count analysis to its diagnostics platform, Vetscan Imagyst.

Dr Wendy Talbot BVSc DipECEIM MRCVS, Equine National Veterinary Manager at Zoetis said: “Fast equine faecal egg count results are crucial for the appropriate…

Zoetis is hosting an Equine Parasite Control Masterclass webinar series online, with the remaining live sessions running from 25 March to 28 October 2026.

The sessions are aimed at vets, vet nurses, SQPs and RAMAs involved in anthelmintic prescribing,…

A survey by Zoetis has found that 93% of horse owners not currently vaccinating against equine herpes virus would do so if their vet recommended it.¹

The survey of 2,256 horse owners examined current EHV vaccination rates, owner understanding of the disease…

Zoetis is asking equine practices to help with the development of new tools to assess health-related quality of life in horses, by asking clients to complete a short (5-8 mins) prototype survey.

Veterinary surgeons will also be asked to verify each horse…

Zoetis has announced a further delay in the supply of Equip Artervac in the UK, due to a manufacturing issue.

The company now expects the vaccine will not be available until June 2025.

The company apologised for the  disruption and inconvenience and says…